Abiopharma

🔍 Eberwein Jeffrey E. (Director)

Company: Star Equity Holdings, Inc. (STRR)

Report Date: 2026-03-19

Detailed Transactions and Holdings:

• Acquired 20,210 shares of Common Stock (Direct)
  Date: 2026-03-19 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,033,737.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: On January 24, 2025 (the "Grant Date"), the restricted stock units ("RSUs") were granted to the Reporting Person under the Issuer's 2009 Incentive Stock and Awards Plan, as amended and restated (the "2009 Incentive Plan") for which the performance conditions related to vesting were satisfied as of March 19, 2026. The RSUs granted are subject to time-based vesting conditions that vest 66.66% on the first anniversary of the Grant Date (13,460 RSUs), 16.7% on the second anniversary of the Grant Date (3,375 RSUs), and 16.7% on the third anniversary of the Grant Date (3,375 RSUs).
• F2: Includes (i) 14,621 shares of restricted stock credited to the Reporting Person's account under the Issuer's 2009 Incentive Plan ; (ii) 6,750 RSUs; and (iii) 1,012,366 shares of common stock. Excludes 1,690 shares indirectly owned in contributory 401(k) and IRA accounts. Each share of restricted stock and each RSU shall vest upon the first anniversary of the grant date and represents the right to receive, at settlement, one share of common stock.